on Facebook
on Twitter
on YouTube
Research Highlights Archive: Aging and Health
2009 — 2008 — 2007 — 2006 — 2005 — 2004 and Prior
2009
Research Highlights represent a selected portion of RAND Health research. For more, browse all RAND Health research.
Does Medicare save lives? — November 18, 2009
Once patients become eligible for Medicare, they receive more services and their mortality rates drop.
Can larger insurers bargain for lower drug prices under Medicare Part D? — October 9, 2009
This study found that insurers with larger enrollments of Part D patients can negotiate for lower drug prices, especially for drugs with therapeutic substitutes.
Prevention would pay off — October 9, 2009
Making older Americans healthier would increase longevity with little or no additional lifetime medical spending.
Does Medicare matter? — April 23, 2009
Getting Medicare coverage at age 65 for the previously uninsured does not significantly improve their health.
How are the baby boomers doing? — April 2009
Mortality rates are about one-third lower for 59-year olds, the leading edge of the baby boomers, compared with people who were 59 in 1982. But reports of cardiovascular disease, obesity, diabetes, and lung disease have increased.
Annual price growth for private pay nursing home care outpaced overall price growth and growth in the price of medical care — March 5, 2009
Estimates of annual private prices for nursing home care between 1977 and 2004 show that nursing home prices are increasing more rapidly than prices for medical care in general, suggesting increased financial pressure on Medicaid programs.
Care for falls, urinary incontinence, and dementia remains inadequate — March 3, 2009
A practice-based intervention integrated into usual clinical care can improve primary care for falls and urinary incontinence, but even with the intervention, less than half of the recommended care for these conditions was provided.
Who should tell patients about new meds? — March 3, 2009
Patients, pharmacists, and physician groups all agree that someone should explain the side effect of new medications to a patient. But there's no agreement about who should provide the information.
Top